David Limal
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Limal.
Vaccine | 1999
Fred Brown; Nadia Benkirane; David Limal; Hubert Halimi; John F.E Newman; Marc H.V. Van Regenmortel; Jean-Paul Briand; Sylviane Muller
The major immunogenic site of foot-and-mouth disease virus (FMDV) is contained in a disordered loop comprising residues 134-158 of capsid protein VP1, located on the surface of the viral particle. Peptides corresponding to this sequence generally elicit protective levels of neutralizing antibodies in guinea pigs. In some instances, however, the level of neutralizing antibodies is low although the level of antibodies against the peptide, determined by ELISA, is as high as that in the sera with high neutralizing antibody titres. In an attempt to ascertain the reason for this difference, we have synthesized on a cellulose membrane 10 overlapping decapeptides, offset by one residue, covering the segment 141-159 of VP1 of two viruses belonging to serotypes A12 and O1, and tested them with guinea pig antisera raised against peptide 141-159, VP1 and FMDV particles (SPOTscan method). With type A, some peptides which were strongly positive with highly neutralizing antisera did not include the RGD triplet located at residues 145-147. In contrast, antisera with low neutralization titres reacted only with decapeptides which included the RGD motif. Moreover, peptide 147-156 coupled to keyhole limpet haemocyanin, but not peptide 141-149 coupled to the same carrier, elicited high levels of neutralizing antibodies in guinea pigs. In the case of serotype O, highly neutralizing antisera to virus reacted in ELISA with peptides 141-150 (containing the RGD motif) and 135-144 (located upstream from the RGD motif). The results suggest that the RGD triplet is not an indispensable constituent of peptides able to elicit a neutralizing antibody response against the virus.
Tetrahedron Letters | 1994
David Limal; Vincent Grand; Régis Vanderesse; Michel Marraud; André Aubry
Abstract The semicarbazone moiety (CCHNNRCONHC), either obtained by coupling a peptide aldehyde with a semicarbazide, or by action of an alkylisocyanate on a peptide hydrazone, is a dipeptide isostere. The structure of four imino aza dipeptides, analogues of the Pro-Gly, Pro-Ala and Pro-Phe dipeptides, has been studied in solution by 1 H-NMR and IR spectroscopy, and in the solid state by X-ray diffraction.
Tetrahedron Letters | 1998
David Limal; Anne Quesnel; Jean-Paul Briand
Abstract A rapid and efficient one-step synthesis of N-protected β-amino dimethylhydroxamates starting from diazo ketones is reported. A Fmoc-protected β-amino aldehyde obtained by reduction of its corresponding dimethylhydroxamate was incorporated during solid phase assembly of an antigenic peptide. The resulting pseudopeptide containing an ethylene amino bond Ψ[CH 2 CH 2 NH] was efficiently recovered.
Archive | 2001
Alberto Bianco; Julien Furrer; Martial Piotto; Maryse Bourdonneau; David Limal; Gilles Guichard; Karim Elbayed; Jésus Raya; Jean-Paul Briand
High-resolution magic angle spinning (HRMAS) NMR spectroscopy is a very promising technique in the field of solid phase organic chemistry for the analysis of resin-bound compounds, including small molecules and peptides [1,2]. We have successfully applied HRMAS NMR to the conformational study of bioactive peptides covalently attached to different resins [3]. The combination of the swelling and solvation properties of resin-bound peptides with the chemico-physical nature of the solid supports plays a fundamental role in the characterization of such conjugates by HRMAS technique. The secondary structure adopted by the sequence 141GSGVRGDFGSLAPRVARQL159, which delineates the major antigenic site of the viral protein VP1 of foot-and-mouth disease virus (FMDV), bound to three different types of resin, namely MBHA, PEGA and POEPOP, has been determined and compared with that of the same peptide free in solution.
Vaccine | 2007
Laurent Mascarell; Laurence Van Overtvelt; Vincent Lombardi; Alain Razafindratsita; Hélène Moussu; S. Horiot; Henri Chabre; David Limal; Stephane Moutel; Jacques Bauer; Carlo Chiavaroli; Philippe Moingeon
Journal of the American Chemical Society | 2001
Julien Furrer; Martial Piotto; Maryse Bourdonneau; David Limal; Gilles Guichard; Karim Elbayed; Jésus Raya; Jean-Paul Briand; Alberto Bianco
Journal of Peptide Research | 2009
David Limal; Jean-Paul Briand; Pascal Dalbon; Michel Jolivet
ACS Combinatorial Science | 2000
Alberto Bianco; Julien Furrer; David Limal; Gilles Guichard; Karim Elbayed; Jésus Raya; Martial Piotto; Jean-Paul Briand
Journal of Molecular Biology | 2002
Angélique Phan Chan Du; David Limal; Vincent Semetey; Hayet Dali; Michel Jolivet; Claude Desgranges; Manh Thong Cung; Jean-Paul Briand; Marie-Christine Petit; Sylviane Muller
Journal of the American Chemical Society | 1998
Régis Vanderesse; Vincent Grand; David Limal; André Vicherat; Michel Marraud; Claude Didierjean; André Aubry